<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Genet</journal-id>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26442099</article-id>
<article-id pub-id-type="pmc">4584971</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2015.00281</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Aging and chronic administration of serotonin-selective reuptake inhibitor citalopram upregulate Sirt4 gene expression in the preoptic area of male mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wong</surname>
<given-names>Dutt Way</given-names>
</name>
<uri xlink:href="http://loop.frontiersin.org/people/269226/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Soga</surname>
<given-names>Tomoko</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/93314/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Parhar</surname>
<given-names>Ishwar S.</given-names>
</name>
<uri xlink:href="http://loop.frontiersin.org/people/68196/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff>
<institution>Brain Research Institute, School of Medicine and Health Sciences, Monash University Malaysia</institution>
<country>Selangor, Malaysia</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Shin Murakami, Touro University California, USA</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Ruth Luthi-Carter, University of Leicester, UK; Jie Shen, Hangzhou Dianzi University, China; Xingguo Liu, Guangzhou Institutes of Biomedicine and Health, China</p>
</fn>
<corresp id="fn001">*Correspondence: Tomoko Soga, Brain Research Institute, School of Medicine and Health Sciences, Monash University Malaysia, Jalan Lagoon Selatan, 47500 Bandar Sunway, Selangor, Malaysia <email xlink:type="simple">tomoko.soga@monash.edu</email></corresp>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Genetics of Aging, a section of the journal Frontiers in Genetics</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>9</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<volume>6</volume>
<elocation-id>281</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>3</month>
<year>2014</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>8</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2015 Wong, Soga and Parhar.</copyright-statement>
<copyright-year>2015</copyright-year>
<copyright-holder>Wong, Soga and Parhar</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Sexual dysfunction and cognitive deficits are markers of the aging process. Mammalian sirtuins (SIRT), encoded by <italic>sirt 1-7</italic> genes, are known as aging molecules which are sensitive to serotonin (5-hydroxytryptamine, 5-HT). Whether the 5-HT system regulates SIRT in the preoptic area (POA), which could affect reproduction and cognition has not been examined. Therefore, this study was designed to examine the effects of citalopram (CIT, 10 mg/kg for 4 weeks), a potent selective-serotonin reuptake inhibitor and aging on SIRT expression in the POA of male mice using real-time PCR and immunocytochemistry. Age-related increases of <italic>sirt1, sirt4, sirt5, and sirt7</italic> mRNA levels were observed in the POA of 52 weeks old mice. Furthermore, 4 weeks of chronic CIT treatment started at 8 weeks of age also increased <italic>sirt</italic>2 and <italic>sirt</italic>4 mRNA expression in the POA. Moreover, the number of SIRT4 immuno-reactive neurons increased with aging in the medial septum area (12 weeks = 1.00 ± 0.15 vs. 36 weeks = 1.68 ± 0.14 vs. 52 weeks = 1.54 ± 0.11, <italic>p</italic> &lt; 0.05). In contrast, the number of sirt4-immunopositive cells did not show a statistically significant change with CIT treatment, suggesting that the increase in sirt4 mRNA levels may occur in cells in which <italic>sirt4</italic> is already being expressed. Taken together, these studies suggest that CIT treatment and the process of aging utilize the serotonergic system to up-regulate SIRT4 in the POA as a common pathway to deregulate social cognitive and reproductive functions.</p>
</abstract>
<kwd-group>
<kwd>serotonin</kwd>
<kwd>aging</kwd>
<kwd>reproduction</kwd>
<kwd>sirtuins</kwd>
<kwd>cognition</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">China Postdoctoral Science Foundation<named-content content-type="fundref-id">10.13039/501100002858</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="6"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="51"></ref-count>
<page-count count="9"></page-count>
<word-count count="6011"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Aging of the central nervous system deregulates homeostatic mechanisms responsible for sexual behavior (Davidson et al., <xref ref-type="bibr" rid="B9">1983</xref>), feeding (Weindruch et al., <xref ref-type="bibr" rid="B50">2001</xref>), sleep (Nakamura et al., <xref ref-type="bibr" rid="B35">2011</xref>) and cognition (Barrientos et al., <xref ref-type="bibr" rid="B2">2012</xref>). Sexual dysfunction and cognitive loss are prominent markers of the aging process. The preoptic area (POA) is involved in the hypothalamic-pituitary-gonadal (HPG) axis for the control of reproduction (Larsson and Heimer, <xref ref-type="bibr" rid="B30">1964</xref>). Gonadotropin-releasing hormone (GnRH) is a pivotal molecule synthesize by neurons in the POA that regulates the release of gonadotropins (LH, luteinizing hormone and FSH, follicular stimulating hormone) that are important for reproduction and reproductive behaviors (Tsutsumi and Webster, <xref ref-type="bibr" rid="B45">2009</xref>). The POA including the GnRH neurons receive serotonergic (5-hydroxytrypramine, 5-HT) innervations (Van De Kar and Lorens, <xref ref-type="bibr" rid="B46">1979</xref>; Jennes et al., <xref ref-type="bibr" rid="B26">1982</xref>). Pharmacological manipulations and lesions of the serotonergic system has a negative tone on reproduction (Verma et al., <xref ref-type="bibr" rid="B48">1989</xref>; Kondo and Yamanouchi, <xref ref-type="bibr" rid="B29">1997</xref>; Olivier et al., <xref ref-type="bibr" rid="B36">2011</xref>) and cognitive function (Sibille et al., <xref ref-type="bibr" rid="B41">2007</xref>). During aging, sex steroid deprivation shifts the homeostasis of the HPG axis which results in increase circulating LH and GnRH levels (Chakravarti et al., <xref ref-type="bibr" rid="B7">1976</xref>). Furthermore, increases in LH are associated with decline in cognitive performance (Casadesus et al., <xref ref-type="bibr" rid="B6">2007</xref>). Moreover, an age-related decline in the serotonergic system also leads to cognitive dysfunction (Meltzer et al., <xref ref-type="bibr" rid="B31">1998</xref>). The POA is involved in social cognition (Driessen et al., <xref ref-type="bibr" rid="B14">2014</xref>). Hence, to understand the mechanism of reproductive aging and cognitive loss, it is important to examine the serotonergic system in the POA during aging.</p>
<p>The family of seven sirtuin (SIRT) proteins is involved in the aging mechanism, which may include reproductive aging (Duan, <xref ref-type="bibr" rid="B15">2013</xref>). Sirt activity is governed by its co-activator, nicotinamide adenine dinucleotide (<italic>nad</italic>), inhibitor nicotinamide (<italic>nam</italic>) and the intermediary conversion enzyme nicotinamide mononucleotide adenylyltransferase (<italic>nmnat-1</italic>) (Denu, <xref ref-type="bibr" rid="B13">2005</xref>). All seven SIRT proteins are expressed in the brain (Dali-Youcef et al., <xref ref-type="bibr" rid="B8">2007</xref>). SIRT proteins are involved in energy balance, reproduction and in brain aging (Duan, <xref ref-type="bibr" rid="B15">2013</xref>). SIRT4 controls glutamate metabolism through glutamate dehydrogenase (Haigis et al., <xref ref-type="bibr" rid="B22">2006</xref>), overexpression of which alters synaptic activity similar to serotonin-depleted models (Michaelis et al., <xref ref-type="bibr" rid="B32">2011</xref>). In addition, serotonin1b (5-HT1b) receptor knockout mice, up-regulate <italic>sirt5</italic> in adult male mice, causing early onset of brain aging (Sibille et al., <xref ref-type="bibr" rid="B41">2007</xref>).</p>
<p>Whether the 5-HT system regulates SIRT in the POA, which could affect the HPG axis, reproduction and cognition has not been examined. Treatment with citalopram (CIT), a potent selective-serotonin reuptake inhibitor, shows deficits in sexual behavior in adult mice (Soga et al., <xref ref-type="bibr" rid="B43">2010</xref>) and sexual dysfunction in humans(Montejo et al., <xref ref-type="bibr" rid="B33">2001</xref>), a condition that mimics aging, which has decreased 5-HT synthesis (Hussain and Mitra, <xref ref-type="bibr" rid="B25">2000</xref>). CIT is extremely selective for its transporter, biosynthetic enzymes and receptors and is used pharmacologically to increase endogenous 5-HT levels at the synapse, although, chronic treatment decreases 5-HT synthesis (Moret and Briley, <xref ref-type="bibr" rid="B34">1996</xref>; Bezchlibnyk-Butler et al., <xref ref-type="bibr" rid="B3">2000</xref>; Stenfors et al., <xref ref-type="bibr" rid="B44">2001</xref>). Therefore, this study was design to examine the effect of CIT and aging on <italic>sirt</italic> mRNA and SIRT expression in the POA of male mice using real-time PCR and immunocytochemistry respectively.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title>Animals</title>
<p>Male C57BL/6N mice (CLEA Japan, Inc Tokyo, Japan) aged 12 weeks (weeks) (<italic>n</italic> = 33), 36 weeks (<italic>n</italic> = 8), and 52 weeks (<italic>n</italic> = 16) were maintained under standard conditions at the animal facility of the Brain Research Institute, Monash University Malaysia. These conditions include constant temperature (22°C) and lighting (12 h light/12 h dark cycle with lights on from 12:00 a.m.) with food and water available <italic>ad libitum</italic>. All procedures were approved by Animal Ethics Committee of Monash University (SOBSB/MY/2010/45) and were accordance with the Guidelines for the Care and Use of Animals by Monash University.</p>
</sec>
<sec>
<title>Chronic citalopram treatment</title>
<p>Mice were administered with CIT [10 mg/kg body weight (BW) in 50 μl, C7861, Sigma-Aldrich, Singapore; <italic>n</italic> = 15] or 50 μl vehicle (distilled water; <italic>n</italic> = 15) daily at 9 a.m. by intraperitoneal (i.p) injections for 4 weeks beginning at 8 weeks of age until 12 weeks of age. Mice were used for two studies; gene expression study and immunocytochemical study. For the gene expression study [12 weeks (vehicle), <italic>n</italic> = 9 and 12 weeks CIT, <italic>n</italic> = 9] using the POA and compared with gene expressions of intact aged mice (36 weeks, <italic>n</italic> = 8 and 52 weeks, <italic>n</italic> = 10). For the immunocytochemical study, the POA of adult mice (12 weeks, <italic>n</italic> = 6, 12 weeks CIT, <italic>n</italic> = 6) and mid-age group (52 weeks, <italic>n</italic> = 6) was used. In this experiment, 52 weeks C57BL/6 male mice represented the reproductive aging model. This strain of mice at 52 weeks begin to exhibit declining male fertility (Fox et al., <xref ref-type="bibr" rid="B19">2006</xref>) characterized by an increase in abnormal spermatozoa leading to ejaculatory disorders (Fabricant and Parkening, <xref ref-type="bibr" rid="B17">1982</xref>), decrease in pheromone production (Wilson and Harrison, <xref ref-type="bibr" rid="B51">1983</xref>), and a decrease in sexual arousal (Bronson and Desjardins, <xref ref-type="bibr" rid="B5">1982</xref>). Additionally, at 52 weeks old these mice begin to experience age-related cognitive decline (Pettan-Brewer et al., <xref ref-type="bibr" rid="B38">2013</xref>).</p>
</sec>
<sec>
<title>Real-time PCR quantification of <italic>sirt1-7, nam</italic> and <italic>nmnat-1</italic> in the POA</title>
<p>At various ages (12weeks, 12weeks CIT, 36weeks, and 52weeks), animals were deeply anaethesized with an i.p. injection of ketamine xylazine (4.5 mg/kg/BW) followed by rapid removal of the brain and snap frozen. The POA (bregma +0.98 to +0.26, 8–11 sections/brain) was cut on a cryostat (60 μm/section) and each section further dissected with a sterile blade under naked eye (Figure <xref ref-type="fig" rid="F1">1A</xref>). Total RNA from these tissues was extracted using TRIzol (Invitrogen, Carlsbad, CA, USA) and transcribed using High Capacity Transcription Kit (Applied Biosystems, Foster City, CA, USA) according to manufacturer's protocols. Quantitative real-time PCR was performed on a ABI 7300 (Applied Biosystems Foster City, CA, USA) using 2X Power SYBR Green PCR mix (Applied Biosystems), and 0.2M primers for <italic>sirt1-7, nam</italic>, and <italic>nmnat-1</italic> (Supplementary Table <xref ref-type="supplementary-material" rid="SM1">1</xref>) in a final volume of 10 μl. The resulting PCR products were validated using an ABI PRISM 310 Genetic Analyzer and Sequence Analysis Software (Applied Biosystems) and ran on a 2.5% agarose gel with ethidium bromide used for visualization.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p><bold>Aging induces <italic>sirt</italic> gene expression in the preoptic area</bold>. <bold>(A)</bold> Representative brain sections depicting areas dissected for gene expression studies in the POA. <bold>(B)</bold> Quantitative real-time PCR revealed differential <italic>sirt</italic> expression changes. Data are expressed as mean ± SEM. Statistical analysis was carried out using one-way analysis of variance (12 weeks control, <italic>n</italic> = 9; 36 weeks, <italic>n</italic> = 8; 52 weeks, <italic>n</italic> = 10). <sup>*</sup><italic>P</italic> &lt; 0.05 and <sup>#</sup><italic>P</italic> &lt; 0.01 vs. control.</p>
</caption>
<graphic xlink:href="fgene-06-00281-g0001"></graphic>
</fig>
</sec>
<sec>
<title>SIRT4 immunocytochemistry</title>
<p>Male mice at 12 weeks (control, <italic>n</italic> = 6; 12 weeks CIT, <italic>n</italic> = 6) and 52 weeks of age (control, <italic>n</italic> = 6) were anaesthesized with an i.p. injection of ketamine xylazine (4.5 mg/kg) and perfused transcardially with 4% paraformaldehyde (PFA) in 0.1M phosphate buffer (pH 7.5). The brains were removed, postfixed for 4 h in 4% PFA, and cryoprotected in 30% sucrose overnight. The POA (bregma +0.98 to +0.26 mm) was then sectioned at 30 μm in the coronal plane into three equal series. A set of sections was incubated for 20 min at 60°C in sodium citrate (pH 6) to unmask antigen epitopes. Prior to incubation in blocking solution (0.25% bovine serum albumin and 1.0% Triton X in 0.1M PBS) for 1 h with tissues were washed twice in 0.1M phosphate buffer saline (PBS) for 10 min each. Subsequently, the same 0.1M PBS wash was conducted on tissues prior to every incubation step. Sections were then incubated for 48 h at 4°C in a polyclonal goat anti-SIRT4 antibody (ab10140, Abcam, USA) at 1:500 dilution in blocking solution. Next, tissues were incubated with biotinylated rabbit anti-goat (Vector Laboratories, Burlingame, CA, USA) at 1:300 dilution in blocking solution for 1 h. Following this, sections were incubated in avidin-peroxidase (1:100 Vector Laboratories) and immunoreactive signal was observed using nickel-enhanced 3,3′-diaminobenzidine hydrochloride (Sigma). Sections were thoroughly washed in PBS and mounted on SuperFrost Plus slides (Fisher Scientific, Pittsburgh, PA, USA), air-dried, dehydrated in ethanol followed by xylene. Finally, the slides were coverslipped with DPX mounting medium.</p>
</sec>
<sec>
<title>Double-label immunofluorescence</title>
<p>Coronal POA sections (30 μm) from male mice at 12 weeks (<italic>n</italic> = 3) were used for double immunohistochemistry with NeuN or GFAP and antisera to SIRT4 as described above. Tissue sections were incubated in Alexa Fluor 488 Anti-Goat (1:200, A11055, Molecular Probes) for 1 h and then incubated with either polyclonal rabbit antibody against GFAP (1:500, G9269, Sigma) or mouse monoclonal antibody against NeuN (1:500, MAB377, Millipore-Chemicon, Billerica, MA, USA) for 24 h. Sections incubated with antisera to GFAP were incubated with Alexa Fluor 594 Anti-Rabbit (1:200, A11012, Molecular Probes) while those with antisera to NeuN were incubated with Alexa Fluor 594 Anti-Mouse (1:200, A11005, Molecular Probes). After a final 0.1M PBS wash, sections were mounted on SuperFrost plus slides (Fisher Scientific) and coverslipped with VECTASHIELD mounting medium (H-1000, Vector Laboratories).</p>
</sec>
<sec>
<title>Absorption test and SIRT4 antibody specificity</title>
<p>The SIRT4 antibody employed in this study recognizes amino acids 302–314 at the C-terminal. For testing antibody specificity, two procedures were carried out. Firstly, an absorption test was carried out using intact 12 weeks mice POA sections (<italic>n</italic> = 3) at 1:500 SIRT4 antisera pre-absorbed overnight with SIRT4 protein (AB23185; amino acids 302–314, 1 μg/ml, Abcam) in immunohistochemical procedures. Secondly, the primary SIRT4 antibody was omitted from the primary incubation solution. Both pre-absorbed and omission of SIRT4 antisera did not produce any immunoreactive staining.</p>
</sec>
<sec>
<title>SIRT4 immunoreactive analysis</title>
<p>POA sections were viewed using bright-field microscopy (Nikon Eclipse 50i) and images were captured in TIF format (Nikon, Tokyo, Japan). The distribution of SIRT4 immunoreactivity was mapped throughout the mouse forebrain and brainstem. Cell counts for SIRT4 immunoreactive cells in the POA of 12 weeks, 12 weeks CIT treated, and 52 weeks (90 μm apart) were carried out using Image Pro Plus (Media Cybernetics Incorporation, Bethesda, USA). The POA consisting of the medial septum (MS), organum vasculosum of the lamina terminalis (OVLT) and the anterior hypothalamic area (AHA) were defined as per unit area of 500,000 pixels, 400,000 pixels, and 50,000 pixels respectively using Image Pro Plus. For each animal, two anatomically matched tissues per area were captured and used for cell counts. Cell counts were carried out by a researcher blind to the treatment and age. A single SIRT4 immunostained cell in a single focal plane was quantified by Image Pro Plus as 120 pixels. Therefore, any clusters of immunoreactive cells quantified by Image Pro Plus were divided by 120 pixels to obtain cell number counts, only immunostained cells with a full size (120 pixels) nuclei were counted in each image of the POA to make adjustments for double counts, in order to obtain true SIRT4 positive cell numbers. Data is expressed as mean number of identifiable SIRT4-immunoreactive cells.</p>
</sec>
<sec>
<title>Double-label immunofluorescence analysis</title>
<p>The co-localization of NeuN or GFAP with SIRT4 immunoreactive cells was viewed with a 20X objective lens under a fluorescent microscope (Nikon Eclipse 90i, Tokyo, Japan). Sections were viewed using a Texas red filter to observe NeuN and GFAP labeled cells while a fluorescein-isothiocyanate filter was used to observe SIRT4 immunolabeled cells. Images of co-localized cells, SIRT4/NeuN and SIRT4/GFAP, were further captured using a laser scanning confocal microscope (C1si, Nikon) and software (NIS Elements AR v4.0, Nikon). The images were captured at 1024 pixel density using a 20X objective and 3X digital zoom function at every 1.25 μm interval to cover the entire neuronal volume.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>Statistical analysis for the effect of age and treatment (CIT) on sirtuin and NAD was carried out using one-way Analysis of variance (ANOVA) PASW statistic software (Version 17.0 Chicago, IL USA), followed with <italic>post-hoc</italic> analysis, Tukey's test, for comparison of multiple age groups. The effect of CIT was further analyzed using unpaired Student's <italic>t</italic>-test. Significant main interactions from One-Way ANOVA were further analyzed using Student's <italic>t</italic>-test. Statistical analysis for the effect of age and CIT on SIRT4 protein expression was carried out using Two-Way ANOVA using age and region (MS, OVLT and AHA) as factors followed by <italic>T</italic>-test to determine significance. Data are presented as means ± SEM. Significant difference was considered when <italic>p</italic> &lt; 0.05.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec>
<title>Effects of aging on <italic>sirt</italic> expression in the POA</title>
<p>Aging did not alter <italic>sirt2, sirt3</italic>, and <italic>sirt6</italic> gene expression in the POA of male mice. There was an increase in <italic>sirt4</italic> and <italic>sirt5</italic> mRNA expression in the POA during aging [<italic>sirt4</italic>; 12 weeks 1.00 ± 0.15 vs. 36 weeks 1.68 ± 0.14 vs. 52 weeks 1.54 ± 0.11, <italic>F</italic><sub>(2, 27)</sub>= 7.20, <italic>p</italic> &lt; 0.01] and [<italic>sirt5</italic>; 1.00 ± 0.14 vs. 36 weeks 1.69 ± 0.15 vs. 52 weeks 2.02 ± 0.21, <italic>F</italic><sub>(2, 27)</sub>= 10.40, <italic>p</italic> &lt; 0.01] (Figure <xref ref-type="fig" rid="F1">1B</xref>). <italic>Post-hoc</italic> analysis revealed an increase in <italic>sirt4</italic> (12 weeks vs. 52 weeks; <italic>p</italic> &lt; 0.05) and <italic>sirt5</italic> (12 weeks vs. 52 weeks; <italic>p</italic> &lt; 0.05). <italic>sirt1</italic> and <italic>sirt7</italic> showed an increase only during 36 week [sirt1; 12 weeks 1.00 ± 0.11 vs. 36 weeks 1.46 ± 0.07 vs. 52 weeks 1.28 ± 0.12, <italic>F</italic><sub>(2, 27)</sub> = 4.93, <italic>p</italic> &lt; 0.05 and <italic>sirt7;</italic> 12 weeks 1.00 ± 0.14 vs. 36 weeks 1.75 ± 0.11 vs. 52 weeks 1.28 ± 0.09, <italic>F</italic><sub>(2, 27)</sub> = 11.26, <italic>p</italic> &lt; 0.01] (Figure <xref ref-type="fig" rid="F1">1B</xref>). <italic>Post-hoc</italic> analysis for <italic>sirt7 r</italic>evealed a decrease at 52 weeks compared to 36 weeks of age (36 weeks vs. 52 weeks; <italic>p</italic> &lt; 0.05).</p>
</sec>
<sec>
<title>Effects of CIT on <italic>sirt</italic> expression in the POA</title>
<p>Chronic CIT treatment induced an increase in <italic>sirt2</italic> (12 weeks 1.00 ± 0.13 vs. 12 weeks CIT 1.61 ± 0.12, <italic>p</italic> &lt; 0.05) and <italic>sirt4</italic> (12 weeks 1.00 ± 0.15 vs. 12 weeks CIT 1.43 ± 0.13, <italic>p</italic> &lt; 0.05) expression in the POA (Figure <xref ref-type="fig" rid="F2">2</xref>). There was no difference in <italic>sirt3, sirt5, sirt6, and sirt7</italic> levels in the POA after CIT treatment (Figure <xref ref-type="fig" rid="F2">2</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p><bold>Chronic citalopram (CIT) treatment up-regulates <italic>sirt2</italic> and <italic>sirt4</italic> in the preoptic area</bold>. CIT was administered at 10 mg/kg/bodyweight daily in male mice for a duration of 4 weeks leading to relative mRNA changes in <italic>sirt2</italic> and <italic>sirt4</italic> expression in the POA. There was no difference in sirt3, sirt5, sirt6, or sirt7 mRNA levels in the POA after CIT treatment. Data are expressed as mean ± SEM. Statistical analysis was carried out using one-way analysis of variance (12 weeks control, <italic>n</italic> = 9; 12 weeks CIT, <italic>n</italic> = 9). <sup>*</sup><italic>P</italic> &lt; 0.05 vs. control.</p>
</caption>
<graphic xlink:href="fgene-06-00281-g0002"></graphic>
</fig>
</sec>
<sec>
<title>Effects of aging and CIT on <italic>nampt</italic> and <italic>nmnat-1</italic> expression in the POA</title>
<p>CIT and aging had no effect on <italic>nam</italic> and <italic>nmnat-1</italic> expression in the POA (Figure <xref ref-type="fig" rid="F3">3</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p><bold>Nicotinamide adenine dinucleotide (NAD) biosynthethic enzymes were not affected by chronic citalopram (CIT) treatment or aging</bold>. CIT was administered at 10 mg/kg/bodyweight daily in male mice for 4 weeks duration. Data are expressed as mean ± SEM. Statistical analysis was carried out using one way analysis of variance (12 weeks control, <italic>n</italic> = 9; 12 weeks CIT, <italic>n</italic> = 9) aging animals used were 36 weeks (<italic>n</italic> = 8) and 52 weeks (<italic>n</italic> = 10).</p>
</caption>
<graphic xlink:href="fgene-06-00281-g0003"></graphic>
</fig>
</sec>
<sec>
<title>Effects of aging and CIT on SIRT4 protein in the POA</title>
<p>SIRT4 immunoreactive cells were observed in the MS, OVLT and AHA regions (Figure <xref ref-type="fig" rid="F4">4</xref>). We observed SIRT4 protein localized mainly in neurons compared to glial cells in the POA (Figure <xref ref-type="fig" rid="F5">5A</xref>). SIRT4 co-localization with glial cells were observed in areas close to the third ventricle of the preoptic area whereas the vast majority of SIRT4 immunoreactivity was observed in neurons. There was no immunostaining when the antibody was preadsorbed with its corresponding antigen or when the antibody was excluded.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<p><bold>Representative images of SIRT4 immunoreactivity in the medial septum (MS), organum vasculosum of the lamina terminalis (OVLT) and anterior hypothalamic area (AHA) from control, citalopram (CIT) treated and mid-aged samples (52 weeks)</bold>. Scale bar = 100 μm.</p>
</caption>
<graphic xlink:href="fgene-06-00281-g0004"></graphic>
</fig>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption>
<p><bold>Aging but not citalopram (CIT) induced SIRT4 immunoreactive cells in the medial septum (MS)</bold>. <bold>(A)</bold> SIRT4 in the POA was observed to be highly co-localized with neuronal nuclei (NeuN) compared to glial fibrillary acidic protein (GFAP) Scale bar = 10 μm. <bold>(B)</bold> SIRT4 immunoreactive cell counts revealed up-regulation of SIRT4 during aging in the MS but not in the organum vasculosum of the lamina terminalis (OVLT) and anterior hypothalamic area (AHA). However, CIT treatment did not alter any SIRT4 immunoreactive cell counts. <bold>(C)</bold> High magnification image of SIRT4 staining in MS of 12 weeks and 52 weeks. Scale bar = 50 μm. Data are expressed as mean ± SEM. Statistical analysis was carried out using analysis of variance, <sup>#</sup><italic>P</italic> &lt; 0.01 vs. control.</p>
</caption>
<graphic xlink:href="fgene-06-00281-g0005"></graphic>
</fig>
<p>There was an increase in SIRT4 immunoreactive cell counts in the MS of 52weeks aging male mice (12 weeks 421 ± 116, 12 weeks CIT 559 ± 146, 52 weeks 1521 ± 306) [Age effect in the MS, <italic>F</italic><sub>(1, 16)</sub> = 16.98, <italic>p</italic> &lt; 0.01] and <italic>T</italic>-test revealed that SIRT4 immunoreactivity at 52 weeks was higher than 12 weeks (<italic>p</italic> &lt; 0.05) and 12 weeks CIT treated mice (<italic>p</italic> &lt; 0.01) (Figures <xref ref-type="fig" rid="F5">5B,C</xref>). CIT treatment did not alter SIRT4 immunoreactivity in the MS. Age and CIT treatment did not alter SIRT4 expression in the OVLT and AHA (Figure <xref ref-type="fig" rid="F5">5B</xref>).</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>In this study, we observed an age-related up-regulation of <italic>sirt1, sirt4, sirt5</italic>, and <italic>sirt7</italic> gene expression in the POA. The expression patterns of <italic>sirt1, sirt4, sirt5</italic>, and <italic>sirt7</italic> gene were different at 36 and 52 weeks, which suggest that different regulatory factors might be involved in their control. Higher levels of <italic>sirt4</italic> and <italic>sirt5</italic> mRNA at 52 weeks may be linked with a decrease in 5-HT (Hussain and Mitra, <xref ref-type="bibr" rid="B25">2000</xref>) and a decrease in testosterone levels (Eleftheriou and Lucas, <xref ref-type="bibr" rid="B16">1974</xref>; De Marte and Enesco, <xref ref-type="bibr" rid="B12">1986</xref>) which are observed during the aging process. In contrast to <italic>sirt4</italic> and <italic>sirt5</italic> expression pattern in the POA, the expression level of <italic>sirt7</italic> was higher in 36 weeks than in 52 weeks old animals. This could be due to an overall decrease in transcription activity in the brain at 52 weeks or due to hypothalamic neurodegeneration that begins at 36 weeks (Bourre and Piciotti, <xref ref-type="bibr" rid="B4">1992</xref>). Since <italic>sirt1</italic> is an age induced gene (Duan, <xref ref-type="bibr" rid="B15">2013</xref>), the increase expression of <italic>sirt1</italic> in the POA of 36 weeks old animals was not unexpected. <italic>Sirt 1</italic> gene expression may be regulated by site-specific modulation in the brain. As <italic>sirt</italic> 1 gene is a regulator of metabolic functions, centrally through the hypothalamus (Duan, <xref ref-type="bibr" rid="B15">2013</xref>), up-regulation of sirt1 gene expression may be due to metabolic changes at 36 weeks in the POA.</p>
<p>CIT treatment up-regulated only <italic>sirt2</italic> and <italic>sir4</italic> gene in the POA. Sirt1 remained unchanged following CIT treatment as it does not respond to SSRI-class of antidepressant (Kishi et al., <xref ref-type="bibr" rid="B27">2011</xref>). This suggests that the effect of CIT on <italic>sirt1</italic> might involve factors aside from 5-HT that change in the male HPG axis during aging (Veldhuis, <xref ref-type="bibr" rid="B47">2008</xref>). CIT treatment may affect <italic>sirt2</italic> gene through 5-HT signaling in the POA, since <italic>sirt2</italic> gene up-regulation is also seen in patients during remission state of depression (Abe et al., <xref ref-type="bibr" rid="B1">2011</xref>). On the other hand, <italic>sirt4</italic> gene expression is regulated by age and CIT in the POA. A decrease in 5-HT during aging (Hussain and Mitra, <xref ref-type="bibr" rid="B25">2000</xref>) has been linked with neurodegenerative diseases (Glorioso et al., <xref ref-type="bibr" rid="B21">2011</xref>), decreased gonadotropin release and cognitive loss (Alzheimer's disease) (Simpkins et al., <xref ref-type="bibr" rid="B42">1977</xref>; Meltzer et al., <xref ref-type="bibr" rid="B31">1998</xref>). Antidepressants like CIT and fluvoxamine cause sexual dysfunction in rodents (Montejo et al., <xref ref-type="bibr" rid="B33">2001</xref>; Soga et al., <xref ref-type="bibr" rid="B43">2010</xref>), and human (Waldinger et al., <xref ref-type="bibr" rid="B49">2001</xref>). Recent studies have shown that chronic SSRI treatment could decrease 5-HT content and signaling in the brain (Delgado et al., <xref ref-type="bibr" rid="B11">1990</xref>; Hervás and Artigas, <xref ref-type="bibr" rid="B23">1998</xref>), rather than simply facilitating synaptic 5-HT availability (de Jong et al., <xref ref-type="bibr" rid="B10">2006</xref>; Geddes et al., <xref ref-type="bibr" rid="B20">2015</xref>). Therefore, age-related and CIT induced sexual dysfunction and cognitive loss due to the decline in 5-HT in the POA may be mediated by an up-regulation of <italic>sirt4</italic> gene expression.</p>
<p>We speculate that the up-regulation of sirt4 gene expression in the POA might occur through one or several potential mechanisms, such as: (1) the blockade of 5-HT uptake by chronic CIT treatment could decrease presynaptic 5-HT content or desensitize postsynaptic 5-HT receptors; (2) the aging process might be associated with a decrease in 5-HT synthesis or a decline in postsynaptic 5-HT receptors (Figure <xref ref-type="fig" rid="F6">6</xref>). According to our model, any of these events could explain a change in sirt4 expression associated with a decrease in serotonergic tone.</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption>
<p><bold>A hypothetical diagram of sirt4 gene regulation by serotonin (5-HT) in the preoptic area (POA) of intact adult, chronic citalopram (CIT) treated adult and aged animals</bold>. <bold>(A)</bold> In the intact adult, sirt4 gene expression levels do not change; <bold>(B)</bold> in the chronic CIT treated adult, the inhibition of 5-HT re-uptake results in decreased presynaptic 5-HT content (pathway ①) or desensitization of postsynaptic receptors that could subsequently be less activated in the presence of normal, or even increased, synaptic 5-HT concentrations (pathway ②), either of which can result in decreased 5-HT neurotransmission and increased sirt4 gene expression; <bold>(C)</bold> in aged animals, the serotonergic system may be impaired by decreased 5-HT synthesis (pathway ③) or a decrease in postsynaptic 5-HT receptors (dotted receptor) (pathway ④) to explain sirt4 upregulation, or an unknown age related effect could increase sirt4 gene expression. These 5-HT signaling pathways could facilitate sirt4 gene expression in the POA leading to reproductive and cognitive failure. <inline-graphic xlink:href="fgene-06-00281-i0001.jpg"></inline-graphic> 5-HT receptors <inline-graphic xlink:href="fgene-06-00281-i0002.jpg"></inline-graphic> Desensitized 5-HT receptors <inline-graphic xlink:href="fgene-06-00281-i0003.jpg"></inline-graphic> Decrease 5-HT receptors <inline-graphic xlink:href="fgene-06-00281-i0004.jpg"></inline-graphic> 5-HT transporter <inline-graphic xlink:href="fgene-06-00281-i0005.jpg"></inline-graphic> re-uptake <inline-graphic xlink:href="fgene-06-00281-i0006.jpg"></inline-graphic> Inhibition of re-uptake <inline-graphic xlink:href="fgene-06-00281-i0007.jpg"></inline-graphic> increase <inline-graphic xlink:href="fgene-06-00281-i0008.jpg"></inline-graphic> No change in gene expression, ① decrease 5-HT neurotransmission, ② desensitized receptor, ③ decrease 5-HT neurotransmission, ④unknown age-related factors could activate sirt4 gene expression.</p>
</caption>
<graphic xlink:href="fgene-06-00281-g0006"></graphic>
</fig>
<p>The localization of SIRT4 primarily in adult neurons is similar to other members of the SIRT family; SIRT1 and SIRT2 in neurons (Houtkooper et al., <xref ref-type="bibr" rid="B24">2012</xref>). The roles of SIRT1, 2 and 4 in neuronal and glial development have been reported (Prozorovski et al., <xref ref-type="bibr" rid="B39">2008</xref>; Park et al., <xref ref-type="bibr" rid="B37">2012</xref>; Komlos et al., <xref ref-type="bibr" rid="B28">2013</xref>). SIRT4 might function in tandem with other SIRT during early development of glial cells and aging of neurons in the POA. Unlike the increase in <italic>sirt4</italic> mRNA, our failure to observe an increase in the number of SIRT4 immunostained cells in the POA following CIT treatment could be due to the methodology used to detect protein levels. Although, immunohistochemistry is an accepted semi-quantitative measure of protein levels; a subtle change in protein levels within cells could go undetected using immunocytochemistry and thereby result in unaltered SIRT4 cell numbers.</p>
<p>The POA is involved in social cognitive functions such as paternal behavior, social recognition and reproductive behavior (Ferguson et al., <xref ref-type="bibr" rid="B18">2002</xref>). An age-related decline in cognitive and reproductive functions (Meltzer et al., <xref ref-type="bibr" rid="B31">1998</xref>) might be associated with decline in the serotonergic system. The POA is known to project to brain regions important for cognitive functions such as the dorsal raphe that harbors 5-HT neurons and the hippocampus (Sava and Markus, <xref ref-type="bibr" rid="B40">2008</xref>). This suggests that the anatomical and functional connection between the POA and the hippocampus and the dorsal raphe might be involved in age-related cognitive impairment. Inversely, 5-HT neurons are known to project to GnRH neurons in the POA (Jennes et al., <xref ref-type="bibr" rid="B26">1982</xref>). A decrease in 5-HT during aging could decrease GnRH levels through the activation of sirt, which could cause a decrease in LH receptors and GnRH receptors in the hippocampus, resulting in deregulation of the social cognitive functions.</p>
<p>Hence, we suggest that the age-related and CIT-induced activation of <italic>sirt4</italic> gene expression, might be initiated by the decline in 5-HT in the POA which leads to reproductive dysfunction and cognitive deficits.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>Grant sponsor: (1) TS-10-01 (to TS, ISP), Monash University Malaysia. (2) FRGS/1/2011/ST/MUSM/02/1 (TS, IP), Ministry of Higher Education (MOHE), Malaysia.</p>
</ack>
<sec id="s5" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fgene.2015.00281">http://journal.frontiersin.org/article/10.3389/fgene.2015.00281</ext-link></p>
<supplementary-material content-type="local-data" id="SM1">
<label>Supplementary Table 1</label>
<caption>
<p><bold>Sequences of primers used for real-time PCR</bold>.</p>
</caption>
<media xlink:href="Table1.PDF">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>N.</given-names></name><name><surname>Uchida</surname><given-names>S.</given-names></name><name><surname>Otsuki</surname><given-names>K.</given-names></name><name><surname>Hobara</surname><given-names>T.</given-names></name><name><surname>Yamagata</surname><given-names>H.</given-names></name><name><surname>Higuchi</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Altered sirtuin deacetylase gene expression in patients with a mood disorder</article-title>. <source/>J. Psychiatr. Res. <volume>45</volume>, <fpage>1106</fpage>–<lpage>1112</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychires.2011.01.016</pub-id><pub-id pub-id-type="pmid">21349544</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrientos</surname><given-names>R. M.</given-names></name><name><surname>Frank</surname><given-names>M. G.</given-names></name><name><surname>Watkins</surname><given-names>L. R.</given-names></name><name><surname>Maier</surname><given-names>S. F.</given-names></name></person-group> (<year>2012</year>). <article-title>Aging-related changes in neuroimmune-endocrine function: implications for hippocampal-dependent cognition</article-title>. <source/>Horm. Behav. <volume>62</volume>, <fpage>219</fpage>–<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1016/j.yhbeh.2012.02.010</pub-id><pub-id pub-id-type="pmid">22370243</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bezchlibnyk-Butler</surname><given-names>K.</given-names></name><name><surname>Aleksic</surname><given-names>I.</given-names></name><name><surname>Kennedy</surname><given-names>S. H.</given-names></name></person-group> (<year>2000</year>). <article-title>Citalopram–a review of pharmacological and clinical effects</article-title>. <source/>J. Psychiatry Neurosci. <volume>25</volume>, <fpage>241</fpage>–<lpage>254</lpage>. <pub-id pub-id-type="pmid">10863884</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourre</surname><given-names>J. M.</given-names></name><name><surname>Piciotti</surname><given-names>M.</given-names></name></person-group> (<year>1992</year>). <article-title>Delta-6 desaturation of alpha-linolenic acid in brain and liver during development and aging in the mouse</article-title>. <source/>Neurosci. Lett. <volume>141</volume>, <fpage>65</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/0304-3940(92)90335-5</pub-id><pub-id pub-id-type="pmid">1508402</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bronson</surname><given-names>F. H.</given-names></name><name><surname>Desjardins</surname><given-names>C.</given-names></name></person-group> (<year>1982</year>). <article-title>Endocrine responses to sexual arousal in male mice</article-title>. <source/>Endocrinology
<volume>111</volume>, <fpage>1286</fpage>–<lpage>1291</lpage>. <pub-id pub-id-type="doi">10.1210/endo-111-4-1286</pub-id><pub-id pub-id-type="pmid">6811257</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casadesus</surname><given-names>G.</given-names></name><name><surname>Milliken</surname><given-names>E. L.</given-names></name><name><surname>Webber</surname><given-names>K. M.</given-names></name><name><surname>Bowen</surname><given-names>R. L.</given-names></name><name><surname>Lei</surname><given-names>Z.</given-names></name><name><surname>Rao</surname><given-names>C. V.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Increases in luteinizing hormone are associated with declines in cognitive performance</article-title>. <source/>Mol. Cell. Endocrinol. <volume>269</volume>, <fpage>107</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2006.06.013</pub-id><pub-id pub-id-type="pmid">17376589</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakravarti</surname><given-names>S.</given-names></name><name><surname>Collins</surname><given-names>W. P.</given-names></name><name><surname>Forecast</surname><given-names>J. D.</given-names></name><name><surname>Newton</surname><given-names>J. R.</given-names></name><name><surname>Oram</surname><given-names>D. H.</given-names></name><name><surname>Studd</surname><given-names>J. W.</given-names></name></person-group> (<year>1976</year>). <article-title>Hormonal profiles after the menopause</article-title>. <source/>Br. Med. J. <volume>2</volume>, <fpage>784</fpage>–<lpage>787</lpage>. <pub-id pub-id-type="doi">10.1136/bmj.2.6039.784</pub-id><pub-id pub-id-type="pmid">974609</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dali-Youcef</surname><given-names>N.</given-names></name><name><surname>Lagouge</surname><given-names>M.</given-names></name><name><surname>Froelich</surname><given-names>S.</given-names></name><name><surname>Koehl</surname><given-names>C.</given-names></name><name><surname>Schoonjans</surname><given-names>K.</given-names></name><name><surname>Auwerx</surname><given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>Sirtuins: the ‘magnificent seven’, function, metabolism and longevity</article-title>. <source/>Ann. Med. <volume>39</volume>, <fpage>335</fpage>–<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1080/07853890701408194</pub-id><pub-id pub-id-type="pmid">17701476</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>J. M.</given-names></name><name><surname>Chen</surname><given-names>J. J.</given-names></name><name><surname>Crapo</surname><given-names>L.</given-names></name><name><surname>Gray</surname><given-names>G. D.</given-names></name><name><surname>Greenleaf</surname><given-names>W. J.</given-names></name><name><surname>Catania</surname><given-names>J. A.</given-names></name></person-group> (<year>1983</year>). <article-title>Hormonal changes and sexual function in aging men</article-title>. <source/>J. Clin. Endocrinol. Metab. <volume>57</volume>, <fpage>71</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1210/jcem-57-1-71</pub-id><pub-id pub-id-type="pmid">6602143</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Jong</surname><given-names>T. R.</given-names></name><name><surname>Snaphaan</surname><given-names>L. J.</given-names></name><name><surname>Pattij</surname><given-names>T.</given-names></name><name><surname>Veening</surname><given-names>J. G.</given-names></name><name><surname>Waldinger</surname><given-names>M. D.</given-names></name><name><surname>Cools</surname><given-names>A. R.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats</article-title>. <source/>Eur. Neuropsychopharmacol. <volume>16</volume>, <fpage>39</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.euroneuro.2005.06.004</pub-id><pub-id pub-id-type="pmid">16107310</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delgado</surname><given-names>P. L.</given-names></name><name><surname>Charney</surname><given-names>D. S.</given-names></name><name><surname>Price</surname><given-names>L. H.</given-names></name><name><surname>Aghajanian</surname><given-names>G. K.</given-names></name><name><surname>Landis</surname><given-names>H.</given-names></name><name><surname>Heninger</surname><given-names>G. R.</given-names></name></person-group> (<year>1990</year>). <article-title>Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan</article-title>. <source/>Arch. Gen. Psychiatry
<volume>47</volume>, <fpage>411</fpage>–<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.1990.01810170011002</pub-id><pub-id pub-id-type="pmid">2184795</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Marte</surname><given-names>M. L.</given-names></name><name><surname>Enesco</surname><given-names>H. E.</given-names></name></person-group> (<year>1986</year>). <article-title>Influence of low tryptophan diet on survival and organ growth in mice</article-title>. <source/>Mech. Ageing Dev. <volume>36</volume>, <fpage>161</fpage>–<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1016/0047-6374(86)90017-5</pub-id><pub-id pub-id-type="pmid">3784629</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denu</surname><given-names>J. M.</given-names></name></person-group> (<year>2005</year>). <article-title>Vitamin B3 and sirtuin function</article-title>. <source/>Trends Biochem. Sci. <volume>30</volume>, <fpage>479</fpage>–<lpage>483</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibs.2005.07.004</pub-id><pub-id pub-id-type="pmid">16039130</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Driessen</surname><given-names>T. M.</given-names></name><name><surname>Eisinger</surname><given-names>B. E.</given-names></name><name><surname>Zhao</surname><given-names>C.</given-names></name><name><surname>Stevenson</surname><given-names>S. A.</given-names></name><name><surname>Saul</surname><given-names>M. C.</given-names></name><name><surname>Gammie</surname><given-names>S. C.</given-names></name></person-group> (<year>2014</year>). <article-title>Genes showing altered expression in the medial preoptic area in the highly social maternal phenotype are related to autism and other disorders with social deficits</article-title>. <source/>BMC Neurosci. <volume>15</volume>:<fpage>11</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2202-15-11</pub-id><pub-id pub-id-type="pmid">24423034</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>W.</given-names></name></person-group> (<year>2013</year>). <article-title>Sirtuins: from metabolic regulation to brain aging</article-title>. <source/>Front. Aging Neurosci. <volume>5</volume>:<issue>36</issue>. <pub-id pub-id-type="doi">10.3389/fnagi.2013.00036</pub-id><pub-id pub-id-type="pmid">23888142</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eleftheriou</surname><given-names>B. E.</given-names></name><name><surname>Lucas</surname><given-names>L. A.</given-names></name></person-group> (<year>1974</year>). <article-title>Age-related changes in testes, seminal vesicles and plasma testosterone levels in male mice</article-title>. <source/>Gerontologia
<volume>20</volume>, <fpage>231</fpage>–<lpage>238</lpage>. <pub-id pub-id-type="doi">10.1159/000212019</pub-id><pub-id pub-id-type="pmid">4463147</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabricant</surname><given-names>J. D.</given-names></name><name><surname>Parkening</surname><given-names>T. A.</given-names></name></person-group> (<year>1982</year>). <article-title>Sperm morphology and cytogenetic studies in ageing C57BL/6 mice</article-title>. <source/>J. Reprod. Fertil. <volume>66</volume>, <fpage>485</fpage>–<lpage>489</lpage>. <pub-id pub-id-type="doi">10.1530/jrf.0.0660485</pub-id><pub-id pub-id-type="pmid">7175803</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>J. N.</given-names></name><name><surname>Young</surname><given-names>L. J.</given-names></name><name><surname>Insel</surname><given-names>T. R.</given-names></name></person-group> (<year>2002</year>). <article-title>The neuroendocrine basis of social recognition</article-title>. <source/>Front. Neuroendocrinol. <volume>23</volume>, <fpage>200</fpage>–<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1006/frne.2002.0229</pub-id><pub-id pub-id-type="pmid">11950245</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>J. G.</given-names></name><name><surname>Barthold</surname><given-names>S.</given-names></name><name><surname>Davisson</surname><given-names>M.</given-names></name><name><surname>Newcomer</surname><given-names>C. E.</given-names></name><name><surname>Quimby</surname><given-names>F. W.</given-names></name><name><surname>Smith</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>). <source/>The Mouse in Biomedical Research: Normative Biology, Husbandry, and Models. <publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier Science</publisher-name>.</mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geddes</surname><given-names>S. D.</given-names></name><name><surname>Assadzada</surname><given-names>S.</given-names></name><name><surname>Sokolovski</surname><given-names>A.</given-names></name><name><surname>Bergeron</surname><given-names>R.</given-names></name><name><surname>Haj-Dahmane</surname><given-names>S.</given-names></name><name><surname>Béïque</surname><given-names>J. C.</given-names></name></person-group> (<year>2015</year>). <article-title>Time- dependent modulation of glutamate synapses onto 5-HT neurons by antidepressant treatment</article-title>. <source/>Neuropharmacology
<volume>5</volume>, <fpage>130</fpage>–<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2015.02.027</pub-id><pub-id pub-id-type="pmid">25747603</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glorioso</surname><given-names>C.</given-names></name><name><surname>Oh</surname><given-names>S.</given-names></name><name><surname>Douillard</surname><given-names>G. G.</given-names></name><name><surname>Sibille</surname><given-names>E.</given-names></name></person-group> (<year>2011</year>). <article-title>Brain molecular aging, promotion of neurological disease and modulation by Sirtuin5 longevity gene polymorphism</article-title>. <source/>Neurobiol. Dis. <volume>41</volume>, <fpage>279</fpage>–<lpage>290</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2010.09.016</pub-id><pub-id pub-id-type="pmid">20887790</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haigis</surname><given-names>M. C.</given-names></name><name><surname>Mostoslavsky</surname><given-names>R.</given-names></name><name><surname>Haigis</surname><given-names>K. M.</given-names></name><name><surname>Fahie</surname><given-names>K.</given-names></name><name><surname>Christodoulou</surname><given-names>D. C.</given-names></name><name><surname>Murphy</surname><given-names>A. J.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells</article-title>. <source/>Cell
<volume>126</volume>, <fpage>941</fpage>–<lpage>954</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2006.06.057</pub-id><pub-id pub-id-type="pmid">16959573</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hervás</surname><given-names>I.</given-names></name><name><surname>Artigas</surname><given-names>F.</given-names></name></person-group> (<year>1998</year>). <article-title>Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors</article-title>. <source/>Eur. J. Pharmacol. <volume>358</volume>, <fpage>9</fpage>–<lpage>18</lpage>
<pub-id pub-id-type="doi">10.1016/S0014-2999(98)00579-2</pub-id><pub-id pub-id-type="pmid">9809863</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houtkooper</surname><given-names>R. H.</given-names></name><name><surname>Pirinen</surname><given-names>E.</given-names></name><name><surname>Auwerx</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Sirtuins as regulators of metabolism and healthspan</article-title>. <source/>Nat. Rev. Mol. Cell Biol. <volume>13</volume>, <fpage>225</fpage>–<lpage>238</lpage>. <pub-id pub-id-type="doi">10.1038/nrm3293</pub-id><pub-id pub-id-type="pmid">22395773</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussain</surname><given-names>A. M.</given-names></name><name><surname>Mitra</surname><given-names>A. K.</given-names></name></person-group> (<year>2000</year>). <article-title>Effect of aging on tryptophan hydroxylase in rat brain: implications on serotonin level</article-title>. <source/>Drug Metabol. Dispos. <volume>28</volume>, <fpage>1038</fpage>–<lpage>1042</lpage>. <pub-id pub-id-type="pmid">10950846</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jennes</surname><given-names>L.</given-names></name><name><surname>Beckman</surname><given-names>W. C.</given-names></name><name><surname>Stumpf</surname><given-names>W. E.</given-names></name><name><surname>Grzanna</surname><given-names>R.</given-names></name></person-group> (<year>1982</year>). <article-title>Anatomical relationships of serotoninergic and noradrenalinergic projections with the GnRH system in septum and hypothalamus</article-title>. <source/>Exp. Brain Res. <volume>46</volume>, <fpage>331</fpage>–<lpage>338</lpage>. <pub-id pub-id-type="doi">10.1007/BF00238628</pub-id><pub-id pub-id-type="pmid">7047197</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishi</surname><given-names>T.</given-names></name><name><surname>Fukuo</surname><given-names>Y.</given-names></name><name><surname>Kitajima</surname><given-names>T.</given-names></name><name><surname>Okochi</surname><given-names>T.</given-names></name><name><surname>Yamanouchi</surname><given-names>Y.</given-names></name><name><surname>Kinoshita</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>SIRT1 gene, schizophrenia and bipolar disorder in the Japanese population: an association study</article-title>. <source/>Genes Brain Behav. <volume>10</volume>, <fpage>257</fpage>–<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-183X.2010.00661.x</pub-id><pub-id pub-id-type="pmid">20977650</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komlos</surname><given-names>D.</given-names></name><name><surname>Mann</surname><given-names>K. D.</given-names></name><name><surname>Zhuo</surname><given-names>Y.</given-names></name><name><surname>Ricupero</surname><given-names>C. L.</given-names></name><name><surname>Hart</surname><given-names>R. P.</given-names></name><name><surname>Liu</surname><given-names>A. Y.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Glutamate dehydrogenase 1 and SIRT4 regulate glial development</article-title>. <source/>Glia
<volume>61</volume>, <fpage>394</fpage>–<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22442</pub-id><pub-id pub-id-type="pmid">23281078</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>Y.</given-names></name><name><surname>Yamanouchi</surname><given-names>K.</given-names></name></person-group> (<year>1997</year>). <article-title>Potentiation of ejaculatory activity by median raphe nucleus lesions in male rats: effect of p-chlorophenylalanine</article-title>. <source/>Endocr. J. <volume>44</volume>, <fpage>873</fpage>–<lpage>879</lpage>. <pub-id pub-id-type="doi">10.1507/endocrj.44.873</pub-id><pub-id pub-id-type="pmid">9622305</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsson</surname><given-names>K.</given-names></name><name><surname>Heimer</surname><given-names>L.</given-names></name></person-group> (<year>1964</year>). <article-title>Mating behaviour of male rats after lesions in the preoptic area</article-title>. <source/>Nature
<volume>202</volume>, <fpage>413</fpage>–<lpage>414</lpage>. <pub-id pub-id-type="doi">10.1038/202413a0</pub-id><pub-id pub-id-type="pmid">14152848</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meltzer</surname><given-names>C. C.</given-names></name><name><surname>Smith</surname><given-names>G.</given-names></name><name><surname>Dekosky</surname><given-names>S. T.</given-names></name><name><surname>Pollock</surname><given-names>B. G.</given-names></name><name><surname>Mathis</surname><given-names>C. A.</given-names></name><name><surname>Moore</surname><given-names>R. Y.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging</article-title>. <source/>Neuropsychopharmacology
<volume>18</volume>, <fpage>407</fpage>–<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1016/S0893-133X(97)00194-2</pub-id><pub-id pub-id-type="pmid">9571651</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michaelis</surname><given-names>E. K.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Pal</surname><given-names>R.</given-names></name><name><surname>Bao</surname><given-names>X.</given-names></name><name><surname>Hascup</surname><given-names>K. N.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Neuronal Glud1 (glutamate dehydrogenase 1) over-expressing mice: increased glutamate formation and synaptic release, loss of synaptic activity, and adaptive changes in genomic expression</article-title>. <source/>Neurochem. Int. <volume>59</volume>, <fpage>473</fpage>–<lpage>481</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2011.03.003</pub-id><pub-id pub-id-type="pmid">21397652</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montejo</surname><given-names>A. L.</given-names></name><name><surname>Llorca</surname><given-names>G.</given-names></name><name><surname>Izquierdo</surname><given-names>J. A.</given-names></name><name><surname>Rico-Villademoros</surname><given-names>F.</given-names></name></person-group> (<year>2001</year>). <article-title>Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction</article-title>. <source/>J. Clin. Psychiatry
<volume>62</volume> (<issue>Suppl. 3</issue>), <fpage>10</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="pmid">11229449</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moret</surname><given-names>C.</given-names></name><name><surname>Briley</surname><given-names>M.</given-names></name></person-group> (<year>1996</year>). <article-title>Effects of acute and repeated administration of citalopram on extracellular levels of serotonin in rat brain</article-title>. <source/>Eur. J. Pharmacol. <volume>295</volume>, <fpage>189</fpage>–<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1016/0014-2999(95)00646-X</pub-id><pub-id pub-id-type="pmid">8720583</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>T. J.</given-names></name><name><surname>Nakamura</surname><given-names>W.</given-names></name><name><surname>Yamazaki</surname><given-names>S.</given-names></name><name><surname>Kudo</surname><given-names>T.</given-names></name><name><surname>Cutler</surname><given-names>T.</given-names></name><name><surname>Colwell</surname><given-names>C. S.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Age-related decline in circadian output</article-title>. <source/>J. Neurosci. <volume>31</volume>, <fpage>10201</fpage>–<lpage>10205</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0451-11.2011</pub-id><pub-id pub-id-type="pmid">21752996</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olivier</surname><given-names>B.</given-names></name><name><surname>Chan</surname><given-names>J. S.</given-names></name><name><surname>Snoeren</surname><given-names>E. M.</given-names></name><name><surname>Olivier</surname><given-names>J. D.</given-names></name><name><surname>Veening</surname><given-names>J. G.</given-names></name><name><surname>Vinkers</surname><given-names>C. H.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Differences in sexual behaviour in male and female rodents: role of serotonin</article-title>. <source/>Curr. Top. Behav. Neurosci. <volume>8</volume>, <fpage>15</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1007/7854_2010_116</pub-id><pub-id pub-id-type="pmid">21374021</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S. H.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Ozden</surname><given-names>O.</given-names></name><name><surname>Kim</surname><given-names>H. S.</given-names></name><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>Deng</surname><given-names>C. X.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>SIRT2 is a tumor suppressor that connects aging, acetylome, cell cycle signaling, and carcinogenesis</article-title>. <source/>Transl. Cancer Res. <volume>1</volume>, <fpage>15</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="pmid">22943040</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettan-Brewer</surname><given-names>C.</given-names></name><name><surname>Touch</surname><given-names>D. V.</given-names></name><name><surname>Wiley</surname><given-names>J. C.</given-names></name><name><surname>Hopkins</surname><given-names>H. C.</given-names></name><name><surname>Rabinovitch</surname><given-names>P. S.</given-names></name><name><surname>Ladiges</surname><given-names>W. C.</given-names></name></person-group> (<year>2013</year>). <article-title>A novel radial water tread maze tracks age-related cognitive decline in mice</article-title>. <source/>Pathobiol. Aging Age Relat. Dis. <volume>3</volume>:<fpage>20679</fpage>. <pub-id pub-id-type="doi">10.3402/pba.v3i0.20679</pub-id><pub-id pub-id-type="pmid">24106580</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prozorovski</surname><given-names>T.</given-names></name><name><surname>Schulze-Topphoff</surname><given-names>U.</given-names></name><name><surname>Glumm</surname><given-names>R.</given-names></name><name><surname>Baumgart</surname><given-names>J.</given-names></name><name><surname>Schröter</surname><given-names>F.</given-names></name><name><surname>Ninnemann</surname><given-names>O.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Sirt1 contributes critically to the redox-dependent fate of neural progenitors</article-title>. <source/>Nat. Cell Biol. <volume>10</volume>, <fpage>385</fpage>–<lpage>394</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1700</pub-id><pub-id pub-id-type="pmid">18344989</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sava</surname><given-names>S.</given-names></name><name><surname>Markus</surname><given-names>E. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Activation of the medial septum reverses age-related hippocampal encoding deficits: a place field analysis</article-title>. <source/>J. Neurosci. <volume>28</volume>, <fpage>1841</fpage>–<lpage>1853</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4629-07.2008</pub-id><pub-id pub-id-type="pmid">18287501</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sibille</surname><given-names>E.</given-names></name><name><surname>Su</surname><given-names>J.</given-names></name><name><surname>Leman</surname><given-names>S.</given-names></name><name><surname>Le Guisquet</surname><given-names>A. M.</given-names></name><name><surname>Ibarguen-Vargas</surname><given-names>Y.</given-names></name><name><surname>Joeyen-Waldorf</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Lack of serotonin1B receptor expression leads to age-related motor dysfunction, early onset of brain molecular aging and reduced longevity</article-title>. <source/>Mol. Psychiatry
<volume>12</volume>, <fpage>1042</fpage>–<lpage>1056</lpage>, 1975. <pub-id pub-id-type="doi">10.1038/sj.mp.4001990</pub-id><pub-id pub-id-type="pmid">17420766</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpkins</surname><given-names>J. W.</given-names></name><name><surname>Mueller</surname><given-names>G. P.</given-names></name><name><surname>Huang</surname><given-names>H. H.</given-names></name><name><surname>Meites</surname><given-names>J.</given-names></name></person-group> (<year>1977</year>). <article-title>Evidence for depressed catecholamine and enhanced serotonin metabolism in aging male rats: posssible relation to gondotropin secretion</article-title>. <source/>Endocrinology
<volume>100</volume>, <fpage>1672</fpage>–<lpage>1678</lpage>. <pub-id pub-id-type="doi">10.1210/endo-100-6-1672</pub-id><pub-id pub-id-type="pmid">870310</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soga</surname><given-names>T.</given-names></name><name><surname>Wong</surname><given-names>D. W.</given-names></name><name><surname>Clarke</surname><given-names>I. J.</given-names></name><name><surname>Parhar</surname><given-names>I. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Citalopram (antidepressant) administration causes sexual dysfunction in male mice through RF-amide related peptide in the dorsomedial hypothalamus</article-title>. <source/>Neuropharmacology
<volume>59</volume>, <fpage>77</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2010.03.018</pub-id><pub-id pub-id-type="pmid">20381503</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stenfors</surname><given-names>C.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>Ross</surname><given-names>S. B.</given-names></name></person-group> (<year>2001</year>). <article-title>Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram</article-title>. <source/>Naunyn. Schmiedebergs. Arch. Pharmacol. <volume>363</volume>, <fpage>222</fpage>–<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1007/s002100000347</pub-id><pub-id pub-id-type="pmid">11218075</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsutsumi</surname><given-names>R.</given-names></name><name><surname>Webster</surname><given-names>N. J.</given-names></name></person-group> (<year>2009</year>). <article-title>GnRH pulsatility, the pituitary response and reproductive dysfunction</article-title>. <source/>Endocr. J. <volume>56</volume>, <fpage>729</fpage>–<lpage>737</lpage>. <pub-id pub-id-type="doi">10.1507/endocrj.K09E-185</pub-id><pub-id pub-id-type="pmid">19609045</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van De Kar</surname><given-names>L. D.</given-names></name><name><surname>Lorens</surname><given-names>S. A.</given-names></name></person-group> (<year>1979</year>). <article-title>Differential serotonergic innervation of individual hypothalamic nuclei and other forebrain regions by the dorsal and median midbrain raphe nuclei</article-title>. <source/>Brain Res. <volume>162</volume>, <fpage>45</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(79)90754-6</pub-id><pub-id pub-id-type="pmid">761086</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veldhuis</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Aging and hormones of the hypothalamo-pituitary axis: gonadotropic axis in men and somatotropic axes in men and women</article-title>. <source/>Ageing Res. Rev. <volume>7</volume>, <fpage>189</fpage>–<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2007.12.005</pub-id><pub-id pub-id-type="pmid">18343203</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>S.</given-names></name><name><surname>Chhina</surname><given-names>G. S.</given-names></name><name><surname>Mohan Kumar</surname><given-names>V.</given-names></name><name><surname>Singh</surname><given-names>B.</given-names></name></person-group> (<year>1989</year>). <article-title>Inhibition of male sexual behavior by serotonin application in the medial preoptic area</article-title>. <source/>Physiol. Behav. <volume>46</volume>, <fpage>327</fpage>–<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1016/0031-9384(89)90275-8</pub-id><pub-id pub-id-type="pmid">2602475</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waldinger</surname><given-names>M. D.</given-names></name><name><surname>Zwinderman</surname><given-names>A. H.</given-names></name><name><surname>Olivier</surname><given-names>B.</given-names></name></person-group> (<year>2001</year>). <article-title>SSRIs and ejaculation: a double-blind, randomized, fixed-dose study with paroxetine and citalopram</article-title>. <source/>J. Clin. Psychopharmacol. <volume>21</volume>, <fpage>556</fpage>–<lpage>560</lpage>. <pub-id pub-id-type="doi">10.1097/00004714-200112000-00003</pub-id><pub-id pub-id-type="pmid">11763001</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weindruch</surname><given-names>R.</given-names></name><name><surname>Kayo</surname><given-names>T.</given-names></name><name><surname>Lee</surname><given-names>C. K.</given-names></name><name><surname>Prolla</surname><given-names>T. A.</given-names></name></person-group> (<year>2001</year>). <article-title>Microarray profiling of gene expression in aging and its alteration by caloric restriction in mice</article-title>. <source/>J. Nutr. <volume>131</volume>, <fpage>918S</fpage>–<lpage>923S</lpage>. <pub-id pub-id-type="pmid">11238786</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>M. C.</given-names></name><name><surname>Harrison</surname><given-names>D. E.</given-names></name></person-group> (<year>1983</year>). <article-title>Decline in male mouse pheromone with age</article-title>. <source/>Biol. Reprod. <volume>29</volume>, <fpage>81</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1095/biolreprod29.1.81</pub-id><pub-id pub-id-type="pmid">6615972</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>